Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
2.7 USD
3.45%
Market Closed
Updated:
Apr 26, 2024
Section:
Relative Value
The Relative Value of one
ADPT
stock under the Base Case scenario is
8.39
USD.
Compared to the current market price of 2.7 USD,
Adaptive Biotechnologies Corp
is
Undervalued by 68%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ADPT
Relative Value
Base Case
8.39
USD
Undervaluation 68%
Valuation Multiples
Multiples Across Competitors
ADPT Competitors Multiples
Adaptive Biotechnologies Corp Competitors
Adaptive Biotechnologies Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
391.7m USD | 2.3 | -1.7 | -0.3 | -0.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.6B USD | 5.2 | 37 | 22.8 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
181.8B USD | 7.6 | 38.3 | 25.9 | 36.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.9B CHF | 5.6 | 57.9 | 19.9 | 29.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.3B USD | 6 | 32.6 | 26.1 | 31.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 14.8 | 63.9 | 33.7 | 48.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.8B USD | 7.1 | 34 | 23.8 | 26.4 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 45.2 | 30.9 | 36.9 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.4 | 17.6 | 27.4 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.9B EUR | 7 | 74.2 | 32 | 52.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
